๐๐๐ ๐๐ง๐ ๐๐๐๐๐ ๐๐ญ๐ซ๐๐ง๐ ๐ญ๐ก๐๐ง ๐๐จ๐ฅ๐ฅ๐๐๐จ๐ซ๐๐ญ๐ข๐จ๐ง ๐ญ๐จ ๐๐ง๐ก๐๐ง๐๐ ๐๐๐ง๐ฒ๐โ๐ฌ ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ญ๐๐ง๐๐๐ซ๐๐ฌ ๐๐ง๐ ๐๐จ๐๐๐ฅ ๐๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐ข๐ง๐ – 20TH AUGUST 2024
NAIROBI, KENYA – Today, the Pharmacy and Poisons Board (PPB) welcomed the new USAID Health Director, Bradley Cronk, alongside key representatives from the US Embassy, including Dr. Desmond William, Health Attachรฉ, and a delegate from the United States Trade and Development Agency (USTDA). The high-level visit focused on strengthening collaboration between the two entities.
During the meeting, chaired by PPB Chief Executive Officer Dr. F. M. Siyoi, discussions centered on advancing Kenya’s goal of achieving the World Health Organizationโs Maturity Level 3 status and enhancing local manufacturing capabilities for health products and technologies. Dr. Siyoi expressed deep gratitude for the continuous support from USAID, which has played a crucial role in improving PPBโs service delivery through capacity building and human resource development.
The meeting was also attended by PPB Chairman Dr. Charles Githinji, National Quality Control Laboratory (NQCL) Chairman Dr. John Muturi, Acting Director-NQCL Dr. Mathew Kwena, and representatives from USP and the Promoting the Quality of Medicines Plus (PQM+) program. This collaborative engagement underscores the strong partnership between the PPB and USAID in strengthening Kenyaโs healthcare sector.